SCHEMBL11233734

SCHEMBL11233734

Cc1cncc([C@@H]2CCCN2C)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 5/20 0.46
CHRNA3 P32297 5/20 0.46
CHRNB2 P17787 4/20 0.46
CHRNA4 P43681 4/20 0.46
CHRNA1 P02708 4/20 0.46
CHRNA2 Q15822 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CHRNA7 P36544 2/20 0.46
CHRNG P07510 2/20 0.46
CHRNB1 P11230 2/20 0.46
CHRND Q07001 2/20 0.46
LMNA P02545 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HTR3E A5X5Y0 1/20 0.46
PSIP1 O75475 1/20 0.46
TRPA1 O75762 1/20 0.46
HTR3B O95264 1/20 0.46
MAPT P10636 1/20 0.46
CYP2A6 P11509 1/20 0.46
PTGS1 P23219 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30866547 1.00 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL27200145 1.00 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL31019623 1.00 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Acetic Acid SCHEMBL27199898 0.91 KDM4E (0.43) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Lactic Acid SCHEMBL27199854 0.87 BLM (0.48) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
L-Lactic Acid SCHEMBL27199862 0.87 BLM (0.48) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Cadaverine Tartrate SCHEMBL30866583 0.87 BLM (0.57) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Benzoic Acid SCHEMBL27199910 0.84 BLM (0.44) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL14389477 0.84 ALDH1A1 (0.44) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Levulinic Acid SCHEMBL27199853 0.83 KDM4E (0.38) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11964958-B1 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2024-04-23 US claimed
US-11964958-B1 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2024-04-23 US disclosed
US-4321387-A Process for the preparation of optically active nicotine analogs PHILIP MORRIS, INCORPORATED (US) 1982-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964958-B1 Vaporizable alkaloid compositions and methods of use thereof SRM, SCLY, SMOX CHRNB4 55/4885CHRNA3 116/4885CHRNB2 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.